BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26193124)

  • 1. α-Synuclein dimer structures found from computational simulations.
    Sahu KK; Woodside MT; Tuszynski JA
    Biochimie; 2015 Sep; 116():133-40. PubMed ID: 26193124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic Conformational Preferences and Interactions in α-Synuclein Fibrils: Insights from Molecular Dynamics Simulations.
    Ilie IM; Nayar D; den Otter WK; van der Vegt NFA; Briels WJ
    J Chem Theory Comput; 2018 Jun; 14(6):3298-3310. PubMed ID: 29715424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane-bound structure and energetics of alpha-synuclein.
    Mihajlovic M; Lazaridis T
    Proteins; 2008 Feb; 70(3):761-78. PubMed ID: 17729279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-speed atomic force microscopy reveals structural dynamics of α-synuclein monomers and dimers.
    Zhang Y; Hashemi M; Lv Z; Williams B; Popov KI; Dokholyan NV; Lyubchenko YL
    J Chem Phys; 2018 Mar; 148(12):123322. PubMed ID: 29604892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Insights into the Misfolding and Dimerization Dynamics of the Full-Length α-Synuclein from Atomistic Discrete Molecular Dynamics Simulations.
    Zhang Y; Wang Y; Liu Y; Wei G; Ding F; Sun Y
    ACS Chem Neurosci; 2022 Nov; 13(21):3126-3137. PubMed ID: 36278939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pH on the Aggregation of α-syn12 Dimer in Explicit Water by Replica-Exchange Molecular Dynamics Simulation.
    Cao Z; Zhang X; Liu L; Zhao L; Li H; Wang J
    Int J Mol Sci; 2015 Jun; 16(7):14291-304. PubMed ID: 26114384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein.
    Tsigelny IF; Bar-On P; Sharikov Y; Crews L; Hashimoto M; Miller MA; Keller SH; Platoshyn O; Yuan JX; Masliah E
    FEBS J; 2007 Apr; 274(7):1862-77. PubMed ID: 17381514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the Basis of α-Synuclein Aggregation by Comparing Simulations to Single-Molecule Experiments.
    Churchill CDM; Healey MA; Preto J; Tuszynski JA; Woodside MT
    Biophys J; 2019 Sep; 117(6):1125-1135. PubMed ID: 31477241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope region identification challenges of intrinsically disordered proteins in neurodegenerative diseases: Secondary structure dependence of α-synuclein on simulation techniques and force field parameters.
    Mandaci SY; Caliskan M; Sariaslan MF; Uversky VN; Coskuner-Weber O
    Chem Biol Drug Des; 2020 Jul; 96(1):659-667. PubMed ID: 31903719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Dynamics Study to Investigate the Dimeric Structure of the Full-Length α-Synuclein in Aqueous Solution.
    Zhang T; Tian Y; Li Z; Liu S; Hu X; Yang Z; Ling X; Liu S; Zhang J
    J Chem Inf Model; 2017 Sep; 57(9):2281-2293. PubMed ID: 28796507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-Synuclein misfolding: single molecule AFM force spectroscopy study.
    Yu J; Malkova S; Lyubchenko YL
    J Mol Biol; 2008 Dec; 384(4):992-1001. PubMed ID: 18948117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of mean force and molecular dynamics study on the transient interactions between α and β synuclein that drive inhibition of α-synuclein aggregation.
    Sanjeev A; Sahu RK; Mattaparthi VSK
    J Biomol Struct Dyn; 2017 Nov; 35(15):3342-3353. PubMed ID: 27809690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early oligomerization stages for the non-amyloid component of α-synuclein amyloid.
    Eugene C; Laghaei R; Mousseau N
    J Chem Phys; 2014 Oct; 141(13):135103. PubMed ID: 25296841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of different force fields on the structural character of α synuclein β-hairpin peptide (35-56) in aqueous environment.
    Kundu S
    J Biomol Struct Dyn; 2018 Feb; 36(2):302-317. PubMed ID: 28024449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wild-Type
    Guzzo A; Delarue P; Rojas A; Nicolaï A; Maisuradze GG; Senet P
    Front Mol Biosci; 2022; 9():910104. PubMed ID: 35836937
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of inhibitor-bound alpha-synuclein dimer: role of alpha-synuclein N-terminal region in dimerization and inhibitor binding.
    Yamaguchi Y; Masuda M; Sasakawa H; Nonaka T; Hanashima S; Hisanaga S; Kato K; Hasegawa M
    J Mol Biol; 2010 Jan; 395(3):445-56. PubMed ID: 19895818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures and free energy landscapes of the wild-type and A30P mutant-type α-synuclein proteins with dynamics.
    Wise-Scira O; Aloglu AK; Dunn A; Sakallioglu IT; Coskuner O
    ACS Chem Neurosci; 2013 Mar; 4(3):486-97. PubMed ID: 23374072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational investigation on the effects of H50Q and G51D mutations on the α-Synuclein aggregation propensity.
    Sanjeev A; Mattaparthi VSK
    J Biomol Struct Dyn; 2018 Jul; 36(9):2224-2236. PubMed ID: 28650719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational Study on the Role of γ-Synuclein in Inhibiting the α-Synuclein Aggregation.
    Sanjeev A; Mattaparthi VSK
    Cent Nerv Syst Agents Med Chem; 2019; 19(1):24-30. PubMed ID: 30318002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of EGCG on α-synuclein (αS) aggregation and identification of their possible binding mode: A computational study using molecular dynamics simulation.
    Liu X; Zhou S; Shi D; Bai Q; Liu H; Yao X
    Chem Biol Drug Des; 2018 Jan; 91(1):162-171. PubMed ID: 28667699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.